Health Canada Health Canada has released a warning that ganodeoxyglucuronate may be a “probable” antidepressant.
The warning is a response to a review of studies on the drug by researchers at the University of Manitoba.
The study, published in The American Journal of Psychiatry, found that some studies found a positive effect on sleep, while others found no effect.
The review was funded by the Canadian Institutes of Health Research (CIHR), the country’s largest public health agency.
The university has also released an advisory to researchers, warning that the drug could be dangerous for those who use it to treat insomnia.
Health Canada is warning doctors and patients to avoid using ganaderma lucidus as a treatment for insomnia.
Read more at Health Canada.
Source Google News(Canada) Title Can I take ganidrol to treat my insomnia and other sleep disorders?
article Dr. David L. Nelms, an associate professor at the Johns Hopkins University School of Medicine, says that his own studies have shown that gansidol can be effective for the relief of insomnia.
He’s been prescribing the drug to his patients for more than a decade.
“In the treatment group, I have seen about 60 percent to 80 percent improvement in symptoms,” Dr. Nels says.
“But the benefit of this is that it doesn’t have any side effects, so I can’t prescribe it to everybody.”
Dr. Neses says he has noticed a few positive studies on his patients, but he says the number of studies is so small that there’s no way to be certain.
“I think that if people were to get the drug and take it, they would have to get a certain amount of sleep,” he says.
If you have sleep problems, Dr. J. Scott Hovey, a professor of psychiatry at the Duke University School for the Performing Arts, says it’s important to discuss the use of ganadrol with your doctor.
“If you’re taking it, make sure you know what it’s all about, what you’re doing to try to improve it, what the side effects are and any adverse effects that might be associated with it,” he tells Yahoo Health.
Sources: Health Canada, Health Canada advisory, Johns Hopkins university, Duke University, news source Google